Skip to main content

Vancomycin (International)

In the US, Vancomycin (vancomycin systemic) is a member of the drug class glycopeptide antibiotics and is used to treat Bacteremia, Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Burns - External, Clostridioides difficile Infection, Endocarditis, Enterocolitis, Febrile Neutropenia, Meningitis, Methicillin-Resistant Staphylococcus Aureus Infection, Nosocomial Pneumonia, Peritonitis, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Pseudomembranous Colitis, Sepsis, Shunt Infection, Skin and Structure Infection, Skin or Soft Tissue Infection and Surgical Prophylaxis.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A07AA09,J01XA01

CAS registry number (Chemical Abstracts Service)

0001404-90-6

Chemical Formula

C66-H75-Cl2-N9-O24

Molecular Weight

1449

Therapeutic Category

Glycopeptide antibacterial

Chemical Name

Vancomycin

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs